1 insider bought €770k of shares over the last 90 days, the latest by TU Zhiliang, filed 28 Sept 2026.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 55 declarations
Nearly the whole Gushengtang Holdings Ltd. record runs through one name: TU Zhiliang, Director, files 53 of the 55 filings, of which 36 purchases and 16 sales. The sale of March 24, 2023, worth EUR 64,406,013, is the largest in the record; next come EUR 14,012,353 on January 12, 2023 and EUR 11,429,098 for JIANG Xiaodong, Director, on January 4, 2023. The 18 sales total EUR 125.4 million, with a median of EUR 5,278,529.
The purchases are more numerous but much smaller: 36 purchases, 34 of them with an amount, worth EUR 5.1 million in total with a median of EUR 30,762, so 67% of open-market trades are purchases. The three largest are by TU Zhiliang: EUR 905,272 on November 17, 2025, EUR 732,062 on January 28, 2026 and EUR 404,106 on April 1, 2025.
The 29 filings of the last twelve months are all purchases, and 26 of the 55 filings date from 2026. Filings appear on the same day as the trade at the median (0 days). This Hong Kong company, classed in Health Care, has a market capitalisation of HKD 5.71 billion, with 45.2% of the shares held by insiders. For 15 purchases, the stored 90-day median is 1.2%, with 60% of results positive (recorded past, not a forecast).